Global Regulatory Affairs Outsourcing Market 2023-2029

  • Report Code : 908172
  • Industry : Services
  • Published On : Mar 2023
  • Pages : 63
  • Publisher : Gen Consulting Company
  • Format: WMR PPT FormatWMR PDF Format

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Regulatory affairs outsourcing refers to the practice of hiring external experts or companies to complete various tasks related to regulatory compliance on behalf of a company. These tasks can include market authorization, product registration, and regulatory document submission, among others. It is a critical service used by pharmaceutical, biotechnology, medical device, and other life sciences companies to fulfill regulatory compliance requirements. The global regulatory affairs outsourcing market is likely to register a CAGR of over 13.25% with an incremental growth of USD 11.4 billion during the forecast period 2023-2029. One major driver for the Regulatory Affairs Outsourcing market is the increasing complexities of regulatory requirements across different regions and countries. With the globalization of business and trade, companies need to adhere to a growing number of regulations, guidelines, and standards for their products and services. As a result, it has become a significant challenge for organizations to keep up-to-date with the latest regulatory changes, interpretations, and enforcement policies.One major driver for the Regulatory Affairs Outsourcing market is the increasing complexities of regulatory requirements across different regions and countries. With the globalization of business and trade, companies need to adhere to a growing number of regulations, guidelines, and standards for their products and services. As a result, it has become a significant challenge for organizations to keep up-to-date with the latest regulatory changes, interpretations, and enforcement policies.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global regulatory affairs outsourcing market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, service type, company size, end user, and region. The global market for regulatory affairs outsourcing can be segmented by product: small molecule drugs, biologics, medical devices, others. The small molecule drugs segment captured the largest share of the market in 2022. Regulatory affairs outsourcing market is further segmented by service type: pre-authorization, marketing authorization, post-authorization. The pre-authorization segment held the largest share of the global regulatory affairs outsourcing market in 2022 and is anticipated to hold its share during the forecast period. Based on company size, the regulatory affairs outsourcing market is segmented into: small & mid-sized companies, large-sized companies. In 2022, the small & mid-sized companies segment made up the largest share of revenue generated by the regulatory affairs outsourcing market. On the basis of end user, the regulatory affairs outsourcing market also can be divided into: pharmaceutical, medical device, others. Among these, the pharmaceutical segment was accounted for the highest revenue generator in 2022. Regulatory affairs outsourcing market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By product: small molecule drugs, biologics, medical devices, others
By service type: pre-authorization, marketing authorization, post-authorization
By company size: small & mid-sized companies, large-sized companies
By end user: pharmaceutical, medical device, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides a detailed analysis of several leading regulatory affairs outsourcing market vendors that include IQVIA Holdings, Inc., PPD, Inc., ICON plc, Genpact Limited, PAREXEL International Corporation, Medpace Holdings, Inc., Labcorp Drug Development, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global regulatory affairs outsourcing market.
• To classify and forecast the global regulatory affairs outsourcing market based on product, service type, company size, end user, region.
• To identify drivers and challenges for the global regulatory affairs outsourcing market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global regulatory affairs outsourcing market.
• To identify and analyze the profile of leading players operating in the global regulatory affairs outsourcing market.

Why Choose This Report
• Gain a reliable outlook of the global regulatory affairs outsourcing market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY PRODUCT
Small molecule drugs
Biologics
Medical devices
Others
PART 6. MARKET BREAKDOWN BY SERVICE TYPE
Pre-authorization
Marketing authorization
Post-authorization
PART 7. MARKET BREAKDOWN BY COMPANY SIZE
Small & mid-sized companies
Large-sized companies
PART 8. MARKET BREAKDOWN BY END USER
Pharmaceutical
Medical device
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 10. KEY COMPANIES
IQVIA Holdings, Inc.
PPD, Inc.
ICON plc
Genpact Limited
PAREXEL International Corporation
Medpace Holdings, Inc.
Labcorp Drug Development, Inc.
DISCLAIMER

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
  • Types
  • Applications
  • Technology
  • End-use Industries
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Competitive landscape
It helps the businesses in making strategic decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved